📰 Optimind Pharma News
Optimind Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Optimind Pharma. Real-time updates on events, politics, business and more.
October 14, 2023
Psychedelics therapy provider Optimind Pharma Corp. entered into an acquisition agreement with Wolf Acquisitions 1.0 Corp., an arm's length private British Columbia corporation with investments in the psychedelics industry and one of its wholly-owned subsidiaries.
October 12, 2023
TORONTO, Oct. 12, 2023 -- Optimind Pharma Corp. is pleased to announce that it has entered into an acquisition agreement dated October 12, 2023 with Wolf Acquisitions 1.0 Corp. , an arms length...
September 20, 2022
Optimind looks to accelerate the adoption of the MindSetting TRIP Protocol for ketamine-assisted therapy and other psychedelic enhanced psychotherapy modalities. Toronto, Ontario--(Newsfile Corp. - September
June 16, 2022
Toronto, Ontario--(Newsfile Corp. - June 16, 2022) - Loon Energy Corporation (TSXV: LNE) (the "Company") is pleased to announce that it has applied for listing of its common shares on the Canadian Securities
April 4, 2022
Toronto, Ontario--(Newsfile Corp. - April 4, 2022) - Loon Energy Corporation (TSXV: LNE) (the "Company" or "Loon") and Optimind Pharma Inc. ("Optimind") have entered into a second amending agreement to
December 23, 2021
Toronto, Ontario--(Newsfile Corp. - December 23, 2021) - Loon Energy Corporation (TSXV: LNE) (the "Company" or "Loon") and Optimind Pharma Inc. ("Optimind") have entered into an amending agreement to